All News

Inside this Issue: Editor’s Corner President's Message ISGE Training Programme: Tribute to Frau Sybill Storz Hysteroscopic Myomectomy News from around the World Obituary Letter to the Editor

Inside this Issue: President's Letter Editor's Corner Summary of Sessions from 9th Annual ISGE Conference Gold Coast, Australia Laparoscopy and the anterior abdominal wall: A guide to vascular mapping Pelvic Reconstructive Surgery in The New Millennium Interview from the Gold Coast with Dr. Sciarra Interview from the Gold Coast with Dr Liselotte Mettler, M.D. A Letter from a Past President of ISGE Letters to the Editor Update on Chicago Congress, Letters to the Editor

OBGYN.net Conference CoverageFrom the 11th World Congress on Human Reproduction, June 2002

OBGYN.net Conference CoverageFrom the 11th World Congress on Human Reproduction, June 2002

This month I will discuss a clinical question that is often asked when I lecture about osteoporosis and bone densitometry. The question is when should a clinician obtain a bone densitometry study? To answer the question I will present 2 cases.

Questions this month have been answered by:Barry Gruber, MD, OBGYN.net Osteoporosis Editorial AdvisorHarvey S. Marchbein, MD, USA, OBGYN.net Osteoporosis Chairman and Editorial Advisor

Questions this month have been answered by:Paul D. Burstein, M.D., FACOG OBGYN.net Osteoporosis, Editorial AdvisorClinical Professor Obstetrics & GynecologyUniversity of Wisconsin Medical SchoolMichael Kleerekoper, M.B., B.S.,OBGYN.net Editorial Advisor

Question from Russell: Male Osteoporosis I am 74 years old and had a CATscan 3 weeks ago. The xray doctor said that I had a 70% loss is my spine. My medical Doctor put me on Evista, I have been taking extra calcium along with the Evista. I had been taking Lipitor for high cholesterol but the Dr. took me off of that because my blood platelets had gone down to 121,000. Do you have any suggestions?

A meta-analysis is a systematic review of studies that measures the quality of each study and combines the findings in an unbiased manner.

Recent FDA label changes that put to rest safety concerns about IUDs make them an excellent first-line contraceptive option for most of your patients-even those not in a monogamous relationship.

Recent FDA label changes that put to rest safety concerns about IUDs make them an excellent first-line contraceptive option for most of your patients-even those not in a monogamous relationship.

Obstetricians usually date pregnancies in weeks, from the first day of the last menstrual period.

Dr. Bergh believes single embryo transfer can yield satisfactory delivery rates-but at a price, while Dr. Grainer says we should consider several serious scientific and ethical flaws.

We know that tocolytic agents effectively inhibit uterine contractions, but the evidence for improved perinatal outcomes is much less clear. Why is this so, and what are the implications for your patients?

The Internet has empowered individuals who can now access a huge treasure chest of information quickly. This new age has extraordinary implications for ob/gyns.

‘Overactive bladder’ (OAB) may include increased frequency of urination, urinary urgency, and urge-related incontinence symptoms that occur either alone or in combination.

Understanding the pathophysiology of chemokine secretion in endometriosis may offer a novel area of therapeutic intervention. This study aimed to identify chemokines differentially expressed in epithelial glands in eutopic endometrium from normal women and those with endometriosis, and to establish the expression profiles of key chemokines in endometriotic lesions.

In the May 2006 issue of Obstetrics & Gynecology, the American College of Obstetricians and Gynecologists (ACOG) reaffirmed its recommendation that teenage girls first visit an OB/GYN between the ages of 13 and 15.

A 53 year old woman was investigated for secondary amenorrhea at age 26 and found to have hyperprolactinemia. She took therapy with bromocriptine only for three short periods when she wanted to conceive.

Questions this month have been answered by:Simon Kipersztok, MD, OBGYN.net Osteoporosis Editorial AdvisorHarvey S. Marchbein, MD, USA, OBGYN.net Osteoporosis Chairman and Editorial Advisor

Questions this month have been answered by:R. Wayne Whitted, M.D., M.P.H OBGYN.net Osteoporosis, Editorial AdvisorPaul D. Burstein, M.D., FACOG OBGYN.net Osteoporosis, Editorial Advisor

How useful a role might U/S play in full-term laboring patients for estimating fetal weight, assessing the cervix, and determining fetal position?

Unless operative vaginal delivery can be made at least as safe as cesarean delivery, it will be difficult to justify its continued existence. Proper technique is paramount.

While experts continue to debate the clinical value of electronic fetal monitoring, there's little doubt it's here to stay. Avoiding these 5 common missteps may help you also avoid some common legal minefields.

The cost of malpractice premiums threatens our specialty's very survival. Yet powerful interest groups impede tort reform. What if, however, physicians concede the point that tort reform is not our priority? A strategy of if we can't beat them, join them might ultimately prove the key to the enduring solutions that we seek.

Clinical situations that typically result in litigation and the variation in jury verdicts and awards across the nation.

After reading the latest report from the Women's Health Initiative (WHI), I've struggled with my emotional reaction. The data in this report is not new. The risk of CHD was present only in the oldest women in the trials. . .

Words hurt! We need to choose our words carefully to avoid causing patients unnecessary pain and angst. Your patients will thank you!